Categories: News

Cannabis Suisse Corp. Reports on the Relevance of the Development of the IT Project “Cannabis Life”

DIETIKON, SWITZERLAND / ACCESSWIRE / January 18, 2022 / Cannabis Suisse Corp. (OTC PINK:CSUI), registered in the state of Nevada, is actively engaged in developing its new cannabis IT product.

The concept of the “Cannabis Life” app is to become the leading provider of up-to-date information in the cannabis industry. The application will collect and structure databases on different cannabis strains, products, brands, news and medical research of cannabis. The Company believes that users should have access to objective and scientific information in order to form their own opinion about the industry.

Due to the increasing importance of the industry, more mobile applications began to appear for the convenience of consumers. Before creating the application, the team of the Company did the market research of the existed applications in order to form their own product. The analysis showed that most of the applications perform more than one function. For example, provide the user with information on cannabis strains or dosage.

Working on the development plan, Cannabis Suisse Corp. emphasizes the need to provide its future users with an informative product by combining several functions in one application.

The best solution for future developments is the merge of cannabis with the world of technology. Earlier, the Company already mentioned the relevance of using artificial intelligence technologies in the development of an IT project. AI comprises computer programs and technologies that can imitate human intelligence. As a result, the team working on the project, plans to make an AI chatbot with such a level of communication that will give an impression of interacting with a real person. It will deepen understanding of the cannabis industry.

The Management Board believes that this project will become a new stage in the development of the Company’s business.

ABOUT CANNABIS SUISSE CORP.

Cannabis Suisse Corp. is a public US Company incorporated in Nevada. The Company intends to stay relevant in the field of CBD products. At present, the Company focuses on the IT field applying artificial intelligence technologies. Specifically, Cannabis Suisse Corp. launched the development of the Cannabis Life project. The mobile application comprises different cannabis strains, products, brands, news, and medical research of cannabis collected and structured. The app introduces an AI-chatbot consultant with such a level of communication that will give an impression of interacting with a real person. Cannabis Life is the best innovative solution with artificial intelligence for those, who are interested in the cannabis industry and want as much information as possible.

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that

are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties, and other factors, which may cause the actual results, performance, or achievements of Cannabis Suisse Corp. to be materially different from the statements made herein.

CONTACT:
Alain Parrik
Cannabis Suisse Corp. +41445865314

manage@cannabissuissecorp.com

SOURCE: Cannabis Suisse Corp.

View source version on accesswire.com:
https://www.accesswire.com/684282/Cannabis-Suisse-Corp-Reports-on-the-Relevance-of-the-Development-of-the-IT-Project-Cannabis-Life

Staff

Recent Posts

Revitalist Releases Benefits Program Giving Access To All for Ketamine Therapies Changing the Narrative of Mental Health to Risk Mitigation

Vancouver, British Columbia--(Newsfile Corp. - November 25, 2024) - Revitalist Lifestyle and Wellness Ltd. (CSE:…

2 hours ago

BioHarvest Launches VINIA SuperFood Functional Tea Line

Incremental Product Launch Addresses $3.3 Billion North American Functional Tea Market Opportunity with First SuperFood…

2 hours ago

Neurotech Innovator UNEEG Medical Receives FDA Breakthrough Device Designation Within Monitoring and Diagnostic of Epilepsy

The designation is a result of UNEEG's strong focus on developing novel disease management support…

2 hours ago

Lexaria’s GLP-1 Human Pilot Study #3 Completes Dosing as Scheduled

DehydraTECH-processed tirzepatide from Zepbound® is being tested in an oral dose format KELOWNA, BC /…

2 hours ago

S4 Medical Receives FDA 510(k) Approval for its Redesigned Esophageal Deviation Device and Begins Commercialization

CHAGRIN FALLS, OH / ACCESSWIRE / November 25, 2024 / S4 Medical Corp, an Ohio…

2 hours ago